4//SEC Filing
Sofinnova HealthQuest Partners, L.P. 4
Accession 0001104659-20-014010
CIK 0001447362other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:58 PM ET
Size
8.7 KB
Accession
0001104659-20-014010
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2020-02-06$31.03/sh−25,000$775,750→ 1,733,577 total
Kong Garheng
10% Owner
Transactions
- Sale
Common Stock
2020-02-06$31.03/sh−25,000$775,750→ 1,733,577 total
Sofinnova HealthQuest Partners, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-02-06$31.03/sh−25,000$775,750→ 1,733,577 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019.
- [F2]The shares are directly held by Sofinnova HealthQuest Partners, L.P. ("HealthQuest"). HealthQuest Venture Management, L.L.C. ("HQVM"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.
Documents
Issuer
CASTLE BIOSCIENCES INC
CIK 0001447362
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001579382
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:58 PM ET
- Size
- 8.7 KB